key: cord-0795551-moqjbnoa
authors: nan
title: Parallel sessions
date: 2003-12-31
journal: Hepatology
DOI: 10.1016/s0270-9139(03)80043-5
sha: 94911e2cb4c082fea75d81778ba059f7fa42c914
doc_id: 795551
cord_uid: moqjbnoa

nan

Those posters identified as AASLD Presidential Poster of Distinction by a ribbon icon have received review scores that place them within the top 10% of all posters. We encourage you to make them a priority as you visit the poster session. 

Western Attica General Hospital

UK # 1161 SPECIFIC INHIBITION OF HEPATITIS B VIRUS BY LENTI-VIRAL VECTOR DELIVERED HAMMERHEAD RIBOZYMES

GH Piti6-Salp6tri6re

# 1168 INHIBITORY EFFECT OF ADEFOVIR AND LAMIVUDINE ON THE INITIATION OF HEPATITIS B VIRUS INFECTION IN PRIMARY TUPAIA HEPATOCYTES Josef KOck

# 1170 KINETICS OF VIRAL RESISTANCE AND SERUM HBV DNA IN PATIENTS UNDERLAMIVUDINE THERAPY Michelle Martinot Peignoux, INSERM U481

Mich61e Pouteau, Service d'H6patologie, H6pital Beaujon

# 1171 MOLECULAR EPIDEMIOLOGY OF HEPATITIS B VIRUS IN PATIENTS WITH HBEAG-NEGATIVE/ANTI-HBE-POSITIVE CHRONIC HEPATITIS B FROM DIFFERENT GEOGRAPHICAL AREAS. DATA FROM THE PEGASYS® STUDY IN HBE-ANTIGEN-NEGATIVE CHB

# 1173 COMBINATION THERAPY USING INTERFERON AND LAMIVUDINE IN PEDIATRIC PATIENTS WITH HEPATITIS B

New York Presbyterian Hospital--Columbia

Infectious Diseases Hospital

~0 ~ Pd #1178 I1

# 1179 HEPATITIS B VIRUS GENOTYPES B AND C DO NOT AFFECT THE ANTI-VIRAL RESPONSE TO LAMIVUDINE Man-Fung Yuen

Hong Kong # 1180 ALT FLARES IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B AND TREATED WITH EITHER CONVENTIONAL INTERFERON ALFA-2A OR PEGINTERFERON ALFA-2A (40KD) (PEGASYS®) ARE NOT NECESSARY FOR A SIGNIFICANT RESPONSE TO THERAPY

Teerha Piratvisuth, Songklanakarin Hospital Songkla, Thailand; Georgios Germanidis

Policlinico Umberto I Hospital

IS IT RELATED TO RIBAVIRIN MUTAGENIC PROPERTIES INDUCING ?ERROR CATASTROPHE? Jean-Michel Pawlotsky, Rozenn Brillet, Christophe Hezode, Daniel Dhumeaux

NJ # 1197 INCIDENCE, RISK FACTORS AND TREATMENT OF MOOD DISORDERS ASSOCIATED WITH PEGINTERFERON AND RIBAVIRIN THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C : RESULTS OF A PROSPECTIVE STUDY Laurent Castera, H6pital Haut Ldv~que

Children's Department, Helios Klinikum, Wuppertal, Germany # 1202 COMPARISON OF LOW DOSE WITH STANDARD DOSE PEG-INTERFERON ALFA-2B PLUS RIBAVIRIN FOR INITIAL

Gastro-Biliary Association

H6pital Beaujon

# 1231 SOLUBLE GLYPICAN-3 (SGPC3)

VALIDATION STUDY OF THE NEW PROGNOSTIC STAGING SYSTEM, THE JAPAN INTEGRATED STAGING SCORE (JIS SCORE) FOR HEPATOCELLULAR CARCINOMA IN 3,934 JAPANESE PATIENTS: A MULTICENTER COLLABORATIVE STUDY

Addenbrooke's Hospital

HOMOZYGOSITY FOR THE ALCOHOLDEHYDROGENASE 3"1 ALLELE IS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN ALCOHOL-INDUCED CIRRHOSIS Felix Stickel

Those posters identified as AASLD Presidential Poster of Distinction by a ribbon icon have received review scores that place them within the top 10% of all posters. We encourage you to make them a priority as you visit the poster session.